How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence
The Journal of Allergy and Clinical Immunology: In Practice · 2024-07 · 12 (7) · 1695-1704
DOI: 10.1016/j.jaip.2024.04.048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2024-07. Verfasst von Derek K Chu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Evidence in Allergy Group, Department Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontari…. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Atopic dermatitis (AD) or eczema is a chronic inflammatory skin disease characterized by dry, itchy, and inflamed skin. We review emerging concepts and clinical evidence addressing the pathogenesis and prevention of AD. We examine several interventions ranging from skin barrier enhancement strategies to probiotics, prebiotics, and synbiotics; and conversely, from antimicrobial exposure to vitamin D and omega fatty acid supplementation; breastfeeding and hydrolyzed formula; and house dust mite avoidance and immunotherapy. We appraise the available evidence base within the context of the Grades of Recommendation, Assessment, Development, and Evaluation approach. We also contextualize our findings in relation to concepts relating AD and individual-patient allergic life trajectories versus a linear concept of the atopic march and provide insights into future knowledge gaps and clinical trial design considerations that must be addressed in forthcoming research. Finally, we provide implementation considerations to detect population-level differences in AD risk. Major international efforts are required to provide definitive evidence regarding what works and what does not for preventing AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Evidence in Allergy Group, Department Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada. Electronic address: chudk@mcmaster.ca.
- Child Health Research Centre, University of Queensland, Brisbane, Queensland, Australia; Centre for Food Allergy Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Evidence in Allergy Group, Department Medicine and Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada.
- Centre for Food Allergy Research, Murdoch Children's Research Institute, Melbourne, Victoria, Australia; Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global…
Zitieren
APA
Chu, D. K., Koplin, J. J., Ahmed, T., Islam, N., Chang, C. L., & Lowe, A. J. (2024). How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence. The Journal of Allergy and Clinical Immunology: In Practice, 12(7), 1695-1704. https://doi.org/10.1016/j.jaip.2024.04.048
Vancouver
Chu DK, Koplin JJ, Ahmed T, Islam N, Chang CL, Lowe AJ. How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence. The Journal of Allergy and Clinical Immunology: In Practice. 2024;12(7):1695-1704. doi:10.1016/j.jaip.2024.04.048
BibTeX
@article{Chu2024,
author = {Chu, Derek K and Koplin, Jennifer J and Ahmed, Tasnuva and Islam, Nazmul and Chang, Chia-Lun and Lowe, Adrian J},
title = {How to Prevent Atopic Dermatitis (Eczema) in 2024: Theory and Evidence},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2024},
volume = {12},
number = {7},
pages = {1695--1704},
doi = {10.1016/j.jaip.2024.04.048}
}
EUVIMED